These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2327400

  • 1. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
    Brock JH, Licéaga J, Arthur HM, Kontoghiorghes GJ.
    Am J Hematol; 1990 May; 34(1):21-5. PubMed ID: 2327400
    [Abstract] [Full Text] [Related]

  • 2. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ, Sheppard L, Hoffbrand AV, Charalambous J, Tikerpae J, Pippard MJ.
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [Abstract] [Full Text] [Related]

  • 3. The effect of synthetic iron chelators on bacterial growth in human serum.
    Brock JH, Licéaga J, Kontoghiorghes GJ.
    FEMS Microbiol Immunol; 1988 Jan; 1(1):55-60. PubMed ID: 3272827
    [Abstract] [Full Text] [Related]

  • 4. Site specificity of iron removal from transferrin by alpha-ketohydroxypyridine chelators.
    Kontoghiorghes GJ, Evans RW.
    FEBS Lett; 1985 Sep 09; 189(1):141-4. PubMed ID: 4029396
    [Abstract] [Full Text] [Related]

  • 5. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
    Kontoghiorghes GJ.
    Mol Pharmacol; 1986 Dec 09; 30(6):670-3. PubMed ID: 3785144
    [Abstract] [Full Text] [Related]

  • 6. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
    Kontoghiorghes GJ, Barr J, Nortey P, Sheppard L.
    Am J Hematol; 1993 Apr 09; 42(4):340-9. PubMed ID: 8493983
    [Abstract] [Full Text] [Related]

  • 7. The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.
    Jeremy JY, Kontoghiorghes GJ, Hoffbrand AV, Dandona P.
    Biochem J; 1988 Aug 15; 254(1):239-44. PubMed ID: 3140797
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.
    Kontoghiorghes GJ.
    Toxicol Lett; 1995 Oct 15; 80(1-3):1-18. PubMed ID: 7482575
    [Abstract] [Full Text] [Related]

  • 9. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
    Chua AC, Ingram HA, Raymond KN, Baker E.
    Eur J Biochem; 2003 Apr 15; 270(8):1689-98. PubMed ID: 12694182
    [Abstract] [Full Text] [Related]

  • 10. Effects of chelators on iron uptake and release by the brain in the rat.
    Crowe A, Morgan EH.
    Neurochem Res; 1994 Jan 15; 19(1):71-6. PubMed ID: 8139766
    [Abstract] [Full Text] [Related]

  • 11. Orally active alpha-ketohydroxypyridine iron chelators: effects on iron and other metal mobilisations.
    Kontoghiorghes GJ.
    Acta Haematol; 1987 Jan 15; 78(2-3):212-6. PubMed ID: 3120474
    [Abstract] [Full Text] [Related]

  • 12. Chelators affecting iron absorption in mice.
    Kontoghiorghes GJ.
    Arzneimittelforschung; 1990 Dec 15; 40(12):1332-5. PubMed ID: 2095129
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
    Kontoghiorghes GJ, Chambers S, Hoffbrand AV.
    Biochem J; 1987 Jan 01; 241(1):87-92. PubMed ID: 3566714
    [Abstract] [Full Text] [Related]

  • 14. Effects on Mycobacterium avium replication in normal human macrophages by deferiprone (L1) and other iron chelators. Possible implications on toxicity.
    Douvas GS, May MH, Kolnagou A, Kontoghiorghes GJ.
    Arzneimittelforschung; 2002 Jan 01; 52(1):45-52. PubMed ID: 11838274
    [Abstract] [Full Text] [Related]

  • 15. Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
    Sheppard LN, Kontoghiorghes GJ.
    Arzneimittelforschung; 1993 Jun 01; 43(6):659-63. PubMed ID: 8352819
    [Abstract] [Full Text] [Related]

  • 16. Dose response studies using desferrioxamine and orally active chelators in a mouse model.
    Kontoghiorghes GJ.
    Scand J Haematol; 1986 Jul 01; 37(1):63-70. PubMed ID: 3764334
    [Abstract] [Full Text] [Related]

  • 17. Radiation sensitization of mammalian cells by metal chelators.
    Cook J.
    Radiat Res; 2001 Feb 01; 155(2):304-10. PubMed ID: 11175665
    [Abstract] [Full Text] [Related]

  • 18. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
    Morel I, Cillard J, Lescoat G, Sergent O, Pasdeloup N, Ocaktan AZ, Abdallah MA, Brissot P, Cillard P.
    Free Radic Biol Med; 1992 Nov 01; 13(5):499-508. PubMed ID: 1334028
    [Abstract] [Full Text] [Related]

  • 19. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
    Link G, Pinson A, Hershko C.
    Blood; 1994 May 01; 83(9):2692-7. PubMed ID: 8167347
    [Abstract] [Full Text] [Related]

  • 20. Release of iron by resident and stimulated mouse peritoneal macrophages following ingestion and degradation of transferrin-antitransferrin immune complexes.
    Esparza I, Brock JH.
    Br J Haematol; 1981 Dec 01; 49(4):603-14. PubMed ID: 7317289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.